Skip to content
  • Email:
info@kitherbiotech.com
  • Tel:

XXXXXXX

  • Address:
Via Nizza 52, Torino (Italia)
Kither Biotech
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
×
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact

Kither Biotech announces publication of new data in Science Translational Medicine

Turin, Italy, 31 March 2022 – Data support the use of Kither Biotech’s lead asset, KIT2014, in obstructive airway diseases…

Continue reading

Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer

Turin, Italy, 16 March 2022 – Kither Biotech (“Kither” or “the Company”), a biopharmaceutical company developing novel therapies for rare respiratory diseases…

Continue reading

Kither Biotech welcomes Dr. Vincent Metzler as new Member of the Board

Turin, Italy, 18 June 2020 – We are pleased to announce that Dr. Vincent Metzler has joined the Board of Directors of Kither Biotech…

Continue reading

Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases

Turin, Italy, 5 July 2019 – Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases

Continue reading

Recent articles

  • Kither Biotech announces publication of new data in Science Translational Medicine
  • Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer
  • Kither Biotech welcomes Dr. Vincent Metzler as new Member of the Board
  • Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases
Kither Biotech
Kither Biotech is a biopharmaceutical company developing signal transduction modulators for the treatment of rare respiratory diseases.
Linkedin Youtube
Menu
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
×
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
Contact
  • Via Nizza 52, Torino (Italia)
  • info@kitherbiotech.com
Useful information
  • Privacy Policy
  • Cookie Policy
KITHER BIOTECH S.R.L. © COPYRIGHT 2021-2022. P. IVA 10615040010. DESIGN BY WEB AGENCY TORINO – WEB BRAND